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OBJECTIVE—Insulin stimulates glucose uptake in skeletal
muscle and adipose tissues primarily by stimulating the translo-
cation of vesicles containing a facilitative glucose transporter,
GLUT4, from intracellular compartments to the plasma mem-
brane. The formation of stable soluble N-ethyl-maleimide–
sensitive fusion protein [NSF] attachment protein receptor
(SNARE) complexes between vesicle-associated membrane
protein-2 (VAMP-2) and syntaxin-4 initiates GLUT4 vesicle dock-
ing and fusion processes. Additional factors such as munc18c
and tomosyn were reported to be negative regulators of the
SNARE complex assembly involved in GLUT4 vesicle fusion.
However, despite numerous investigations, the positive regula-
tors have not been adequately clariﬁed.
RESEARCH DESIGN AND METHODS—We determined the
intracellular localization of DOC2b by confocal immunoﬂores-
cent microscopy in 3T3-L1 adipocytes. Interaction between
DOC2b and syntaxin-4 was assessed by the yeast two-hybrid
screening system, immunoprecipitation, and in vitro glutathione
S-transferase (GST) pull-down experiments. Cell surface exter-
nalization of GLUT4 and glucose uptake were measured in the
cells expressing DOC2b constructs or silencing DOC2b.
RESULTS—Herein, we show that DOC2b, a SNARE-related
protein containing double C2 domains but lacking a transmem-
brane region, is translocated to the plasma membrane upon
insulin stimulation and directly associates with syntaxin-4 in an
intracellular Ca
2-dependent manner. Furthermore, this process
is essential for triggering GLUT4 vesicle fusion. Expression of
DOC2b in cultured adipocytes enhanced, while expression of the
Ca
2-interacting domain mutant DCO2b or knockdown of
DOC2b inhibited, insulin-stimulated glucose uptake.
CONCLUSIONS—These ﬁndings indicate that DOC2b is a pos-
itive SNARE regulator for GLUT4 vesicle fusion and mediates
insulin-stimulated glucose transport in adipocytes. Diabetes 58:
377–384, 2009
I
nsulin stimulates glucose uptake in skeletal muscles
and adipose tissues primarily by stimulating the
translocation of vesicles containing a facilitative
glucose transporter, GLUT4, from intracellular com-
partments to the plasma membrane (1,2). In addition to
this translocation step, membrane fusion processes are
also controlled by insulin (3,4). Like other regulated
exocytotic processes in many cell types, the formation of
stable soluble N-ethyl-maleimide–sensitive fusion protein
[NSF] attachment protein receptor (SNARE) complexes
between vesicle-associated membrane protein-2 (VAMP-2)
and syntaxin-4 initiates GLUT4 vesicle docking and fusion
processes (5). However, the precise mechanism by which
insulin regulates SNARE complex assembly remains
poorly understood.
In neurons, Ca
2 triggers exocytotic membrane fusion
of synaptic vesicles to the plasma membrane, and calcium
sensor proteins such as synaptotagmins have critical roles
in this process (6,7). Similar mechanisms result in GLUT4
vesicle fusion in adipocytes and muscle cells. Whitehead
et al. (8) demonstrated, and we conﬁrmed, that reduction
of intracellular Ca
2 ([Ca
2]i) using the membrane-perme-
able Ca
2-chelating agent BAPTA-AM diminished insulin-
stimulated glucose transport, whereas this reagent did not
inhibit GLUT4 translocation to the plasma membrane (i.e.,
GLUT4 vesicle trafﬁcking was not impaired) (8) (N.F.,
M.E., unpublished observation). These observations sug-
gest that an appropriate intracellular Ca
2 level may be
required for the ﬁnal docking/fusion steps of GLUT4
vesicles in adipocytes.
The universal role of Ca
2 as a trigger for regulated
exocytosis predicts the existence of conserved proteins
capable of activating the fusion machinery upon binding
Ca
2. Although many proteins have been suggested to play
such a role, synaptotagmins have attracted the most
attention as putative calcium sensor proteins functioning
in regulated exocytosis (9). Synaptotagmin family proteins
have tandem C2 domains at the C-terminus. These two
domains, C2A and C2B, are conserved in all 13 synapto-
tagmins described to date and constitute Ca
2-binding
modules (10). Many proteins have been identiﬁed as being
involved in the GLUT4 vesicle fusion machinery in adipo-
cytes. However, neither synaptotagmins nor other calcium
sensor proteins have as yet been reported to regulate
GLUT4 vesicle fusion.
We investigated, in detail, the mechanisms of Ca
2-
dependent GLUT4 vesicle fusion in adipocytes. We
searched for double C2 domain proteins as candidate Ca
2
sensor proteins suitable for the relatively slow (on the
order of several minutes) SNARE complex formation, and
we found that DOC2b bound syntaxin-4 upon insulin
stimulation in an intracellular Ca
2-dependent manner and
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stream target of the insulin signal and a positive regulator
of SNARE assembly involving regulated exocytosis in
adipocytes.
RESEARCH DESIGN AND METHODS
Mouse DOC2a and DOC2b cDNA constructs were kindly provided by Dr. R.R.
Duncan (University of Edinburgh, Edinburgh, U.K.). Mouse munc18c cDNA
construct was kindly provided by Dr. T. Takuma (School of Dentistry, Health
Sciences University of Hokkaido, Hokkaido, Japan).
Cell culture. 3T3-L1 ﬁbroblasts were grown in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) with 10% fetal bovine serum (FBS) at 37°C. The cells (3–5
days after conﬂuence) differentiated into adipocytes with incubation in the
same DMEM, containing 0.5 mmol/l isobutylmethylxanthine, 0.25 mol/l
dexamethasone, and 4 g/ml insulin, for 3 days and were then grown in
DMEM with 10% FBS for an additional 5–8 days.
Plasmids and antibodies. Wild-type DOC2b was subcloned into peGFP-C2,
pDsRed2-C1 (Clontech, Palo Alto, CA), and pGEX-6P1 (GH Healthcare,
Buckinghamshire, U.K.) vectors. Calcium interacting domain mutants (CIMs)
of DOC2b (D157N, D163N, D297N, and D303N) were subcloned into peGFP-C2
and pGEX-6P1 vectors. We also constructed syntaxin-4 and a series of deletion
mutants of DOC2b corresponding to munc13 interaction domain (MID)
(amino acids 36–413), C2A (2–120 and 252–413), and C2B (2–264) in a
peGFP-C2 vector. Myc-tagged DOC2b (wild-type or CIM) was subcloned into
a pcDNA3 vector. All chemically synthesized and PCR-derived DNA sequences
were veriﬁed by DNA sequencing.
Rabbit polyclonal DOC2b antibody was generated against the peptide
sequence CGARDDDEDVDQL speciﬁc for DOC2b isoform. This antibody was
found to cross-react minimally (online appendix Fig. S1 [available at http://
dx.doi.org/10.2337/db08-0303). The following antibodies were used: monoclo-
nal anti-GLUT4 (clone 1F8) (R&D systems, Minneapolis, MN), polyclonal
anti-GLUT4, anti-GST (Santa Cruz Biotechnology, Santa Cruz, CA), anti-myc
(clone 9E10) (Covance, Princeton, NJ), polyclonal anti–syntaxin-4 (Synaptic
Systems, Gottingen, Germany), and ﬂuorescent-conjugated and horseradish
peroxidase–conjugated secondary antibodies (Jackson Immuno Research,
West Grove, PA).
DOC2b shRNA construct. Short-hairpin RNA (shRNA) speciﬁc for mouse
DOC2b was designed to have a 5-GCCAGATGTAGACAAGAAATC-3 se-
quence. Synthetic complementary single-stranded DNA of the target sequence
was annealed, and the double-stranded DNA was inserted into a pcPURU6i
cassette (11). This shRNA decreased DOC2b protein expression to 10–20% of
the control level within 74 h. A same cassette encoding nonspeciﬁc scramble
sequence was used as a negative control.
Preparation of recombinant adenovirus vectors. Adenovirus producing
enhanced green ﬂuorescent protein (eGFP), myc-tagged DOC2b (wild type,
CIM mutant), and shRNA (DOC2b, control) were prepared using an AdEasy
adenovirus vector system according to the manufacturer’s instructions (Strat-
agene, Cedar Creek, TX). All ampliﬁed viruses were puriﬁed by the cesium
chloride centrifugation method and stored at 80°C.
Live cell imaging of DOC2b. The peGFP-DOC2b was electroporated into
3T3-L1 adipocytes, which were then reseeded onto 0.1-mm glass-bottom
dishes (Matsunami, Tokyo, Japan). At 24–48 h after electroporation, cells
were serum starved for 3–4 h in DMEM and then incubated at 37°C for2hi n
Krebs-Ringer HEPES buffer (130 mmol/l NaCl, 5 mmol/l KCl, 1.3 mmol/l CaCl2,
1.3 mmol/l MgSO4, 25 mmol/l HEPES [pH 7.4]). The cells were treated with 100
nmol/l of insulin at 37°C for the time indicated and observed by laser confocal
microscopy (LSM510 Pascal; Carl Zeiss, Oberkochen, Germany). For the
translocation analysis, ﬂuorescent intensities at three distinct areas in plasma
membrane, cytosol, and nucleus (nine areas per cell each) of three indepen-
dent cells were analyzed by Photoshop software CS2.
Yeast two-hybrid screening. The Matchmaker Yeast Two-Hybrid System
(Clontech) was used for determination of DOC2b-binding partners. Full-length
DOC2b and munc18c cDNA were subcloned into a pLexA vector and
full-length syntaxin-4 and munc18c cDNA into a pB42AD vector. A standard
lithium acetate/single-stranded carrier DNA/polyethylene glycol method for
transformation into yeast strain EGY48 (p8op-lacZ) was used, and these
proteins were expressed in this strain. Transcriptional activation of LacZ was
determined by an X-Gal assay. -Galactosidase activity was detected within
16 h of reaction at 30°C.
In vitro GST pull-down assay. Glutathione S-transferase (GST) fusion
proteins of wild-type and CIM DOC2b were puriﬁed according to the manu-
facturer’s instructions. GST syntaxin-4 was cleaved with PreScission Protease
(2 units/l) (GH Healthcare) in buffer containing 50 mmol/l Tris-HCl (pH 7.0),
150 mmol/l NaCl, 1 mmol/l EDTA, and 1 mmol/l dithiothreitol at 4°C for 16 h.
At the end of incubation, cleaved syntaxin-4 protein was further puriﬁed using
Amicon Ultra ﬁlter devices (Millipore, Danvers, MA).
Recombinant individual GST-DOC2bs or GST (1 g each) were incubated
with 1 g of recombinant syntaxin-4 in 1 ml of Tris-buffered saline (20 mmol/l
Tris, pH 7.4, 150 mmol/l NaCl) plus 0.5% Triton X-100 in the presence of 2
mmol/l EDTA or 1 mmol/l CaCl2 for 4–6 h. This mixture was immunoprecipi-
tated by incubating with Glutathion Sepharose 4B (GE Healthcare) for 1 h.
The precipitates were washed four times and analyzed by SDS-PAGE and
immunoblotting. Approximately 5% of syntaxin-4 was pulled down by the
GST-DOC2b.
Northern blotting. Total RNAs were prepared from 3T3-L1 ﬁbroblasts,
3T3-L1 adipocytes (days 3 and 9 of differentiation) or rat epididymal fat, and
mouse brain using ISOGEN (Nippongene, Tokyo, Japan) and denatured in
formaldehyde/formamide, resolved by electrophoresis, and transferred to
hybond-N membranes (GH Healthcare). The membranes were hybridized with
-[
32P]–labeled full-length DOC2a and DOC2b cDNAs as probes and then
washed three times with 1 saline sodium citrate buffer (15 mmol/l NaCl, 15
mmol/l sodium citrate [pH 7.0], and 0.1% SDS) at 65°C. Radioisotopic
measurements were conducted using a Phosphorimager FLA2000 (Fuji ﬁlm,
Tokyo, Japan).
Immunoprecipitation and immunoblotting. A 10-cm plate of cells was
lysed in 1 ml of lysis buffer (20 mmol/l HEPES [pH 7.2], 100 mmol/l NaCl, 25
mmol/l NaF, 1 mmol/l sodium vanadate, 1 mmol/l benzamidine, 5 g/ml
leupeptin, 5 g/ml aprotinin, 1 mmol/l phenylmethylsulphonyl ﬂuoride, 1
mmol/l dithiothreitol, and 0.5% NP-40) in the presence of 2 mmol/l EDTA or 1
mmol/l CaCl2 and centrifuged for 15 min at 15,000g. The postnuclear lysates
were used for the following experiments. The protein concentration was
measured with a bicinchoninic acid protein assay reagent (Pierce, IL). For
immunoprecipitation, the cell lysates were preincubated with protein-G/A–
Sepharose at 4°C for 30 min to remove nonspeciﬁc bound proteins. Then,
samples were incubated with primary antibodies at 4°C for 8–12 h followed by
incubation with protein-G/A–Sepharose. Lysates and immunoprecipitates
were resolved by SDS-PAGE and transferred to a polyvinylidene ﬂuoride
membrane (GH Healthcare). The membranes were incubated with primary
antibodies for 8–12 h. Protein signals were visualized using horseradish
peroxidase–conjugated secondary antibodies and an enhanced chemilumines-
cence substrate kit (GH Healthcare). The efﬁciencies of immunoprecipitation
of the associated protein in Fig. 3C–E were 	1, 0.5, and 0.6%, respectively. All
the images in ﬁgures are representative, and we repeated the immunoblots at
least three times and found similar results.
Immunoﬂuorescence microscopy and digital image analysis. Differenti-
ated 3T3-L1 adipocytes were left untreated or electroporated by eGFP-DOC2b
(wild type, CIM, MID, C2A, and C2B), eGFP alone, DsRed2-DOC2b (wild
type, CIM), shRNAs (control, DOC2b), or myc-GLUT4-eGFP. The cells were
then replated onto coverslips and allowed to recover for 48 h. Cells were
preincubated in the presence or absence of 50 mol/l of BAPTA-AM for 10
min, followed by incubation with or without insulin for 20 min at 37°C. Next,
the cells were ﬁxed with 3.7% formaldehyde in PBS and permeabilized with
buffer A (0.5% Triton X-100, 1% FBS in PBS) for 15 min. For the detection of
endogenous proteins, the coverslips were incubated for 2 h with primary
antibodies at room temperature. The cells were washed and incubated with an
appropriate secondary antibody for 30 min. The coverslips were washed
thoroughly again and mounted on glass slides. Immunostained cells were
observed at room temperature with an LSM 5 PASCAL laser-scanning confocal
microscope and its two-channel–scanning module (Carl Zeiss) equipped with
an inverted Zeiss Axiovert 200M using the 63 oil objective lens (numerical
aperture 1.4) run by LSM 5 processing software and Adobe Photoshop CS2. At
least ﬁve cells were observed in a condition. The experiments were repeated
at least three times, unless stated otherwise. All the images in ﬁgures are
representative, and the conclusions are based on qualitative visual impression.
The cell surface myc-GLUT4-eGFP was measured by subtracting the internal
myc signal from total myc signal of electroporated cells. The plasma mem-
brane eGFP content was also measured. The cell surface GLUT4 was
calculated as (total myc  internal myc)/(total eGFP  internal eGFP) (22).
2-Deoxy-glucose uptake. Differentiated adipocytes were prepared in 24-well
plates. Cells were infected with the recombinant adenoviruses. Two days
thereafter, the cells were serum starved for2ha t37°C in Krebs-Ringer HEPES
buffer. Then, the cells were stimulated with or without 100 nmol/l of insulin
for 10 min, and 2-deoxy-glucose uptake was determined by 2-deoxy-D-[2,6
3H] glucose incorporation. Nonspeciﬁc glucose uptake was measured in
the presence of 20 mol/l cytochalasin B and subtracted from each
determination to obtain speciﬁc uptake. The results were normalized by
the protein amount.
Statistical analysis. Multiple comparisons among groups were performed
using one-way ANOVA (post hoc test: Tukey-Kramer). Results are presented
as means 
 SD. Values of P  0.05 were considered statistically signiﬁcant.
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DOC2b translocates to the plasma membrane in re-
sponse to insulin. Type C tandem C2 domain proteins are
classiﬁed into three groups (i.e., synaptotagmin and syn-
aptotagmin-like protein and DOC2 family proteins). The
ﬁrst two groups of proteins regulate relatively fast mem-
brane fusion (on the order of milliseconds to a few
seconds) (12,13). This time scale is not suitable for GLUT4
vesicle fusion. Therefore, we focused on DOC2 family
proteins as candidate regulators of GLUT4 vesicle fusion.
First, we determined the expression proﬁle of DOC2
mRNA in adipocytes. As shown in Fig. 1A, DOC2a was not
expressed in 3T3-L1 adipocytes. According to a previous
study, DOC2 is localized to the nucleus and has no
Ca
2-binding activity because of amino acid substitutions
at the Ca
2-binding sites (14). Thus, we investigated the
function of the DOC2b isoform involved in GLUT4 mem-
brane fusion. Next, we examined the intracellular localiza-
tion of DOC2b in differentiated 3T3-L1 adipocytes using
anti-DOC2b antibody (Fig. 1B) or by expressing an eGFP
fused to DOC2b (Fig. 2A). As shown in Fig. 1B, DOC2b
results in a ﬁne punctate or granular appearance through-
out the cytoplasm under basal conditions. In contrast, the
addition of insulin yields relatively slow (	5 min) translo-
cation of DOC2b to the cell periphery (Fig. 2A). This time
scale of translocation was very similar to that of GLUT4
vesicles. It is noteworthy that deletion of the MID en-
hanced plasma membrane localization even in the absence
of insulin and that the C2B domain is necessary for
membrane targeting (Fig. 2B). These observations are
interesting in considering the distinct roles of the C2A and
C2B domains and the negative regulatory function of MID.
We performed additional experiments to determine the
role of calcium in the translocation of DOC2b. As shown in
Fig. 2C, the cell membrane permeable Ca
2-chelating
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FIG. 1. The expression proﬁles and intracellular localization of DOC2b
in 3T3-L1 adipocytes. A: The expressions of DOC2a and DOC2b in
3T3-L1 ﬁbroblasts, 3T3-L1 adipocytes (days 3 and 9 of differentiation),
rat epididymal fat, and mouse brain were analyzed by mRNA blot. B:
Differentiated 3T3-L1 adipocytes were serum-starved for 3–4 h and
then stimulated with 100 nmol/l of insulin for 20 min, ﬁxed, and
immunostained. The endogenous DOC2b and GLUT4 were visualized
using anti-DOC2b and anti-GLUT4 antibodies and observed by confocal
microscopy. (Please see http://dx.doi.org/10.2337/db08-0303 for a high-
quality digital representation of this ﬁgure.)
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FIG. 2. Insulin augments DOC2b translocation to the plasma mem-
brane. A: 3T3-L1 adipocytes were electroporated with eGFP-DOC2b
and then treated with 100 nmol/l of insulin for the times indicated. Live
ﬂuorescent images of the cells were captured by confocal microscopy.
Relative ﬂuorescences of the plasma membrane, nucleus, and cytosol
were each measured in three distinct areas. At least three cells were
analyzed for each condition. Results are means  SD from three
independent experiments. B: 3T3-L1 adipocytes expressing eGFP-
DOC2b (WT [wild type], MID, C2A, or C2B) were treated with or
without 100 nmol/l of insulin and observed by confocal microscopy. C:
3T3-L1 adipocytes were electroporated with eGFP-DOC2b and then
pretreated with 50 mol/l of BAPTA-AM for 10 min, before treatment
with insulin and observed under a confocal microscope.
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tion of DOC2b.
DOC2b binds syntaxin-4 upon stimulation with insu-
lin. Since DOC2b is thought to be a soluble calcium-
sensing protein, compartment-speciﬁc targeting must be
achieved through interaction with membrane-bound pro-
teins such as SNARE and SNARE-related proteins. There-
fore, we attempted to identify DOC2b-binding partners
among these proteins using a yeast two-hybrid system. We
found a very strong interaction between DOC2b and
syntaxin-4 compared with the already known binding
between munc18c and syntaxin4 (Fig. 3A). Interestingly,
this t-SNARE protein is reportedly a key molecule for
GLUT4 vesicle fusion in response to insulin (5,15). Al-
though this interaction was very strong, SNARE proteins
are quite “sticky” and can on occasion bind with many
proteins nonspeciﬁcally. Therefore, we performed the
following three additional experiments. First, we deter-
mined the direct interaction in vitro using recombinant
proteins, GST-tagged DOC2b, and synthesized syntaxin-4.
As shown in Fig. 3B, the interaction was easily detected by
immunoblotting in the presence of calcium. Second, we
examined endogenous protein-protein interactions by im-
munoprecipitation experiments using polyclonal anti-
DOC2b. As shown in Fig. 3C, insulin treatment increased
DOC2b–syntaxin-4 binding, and BAPTA-AM abolished this
interaction. Since the molecular weights of DOC2b and the
IgG heavy chain are quite similar (computed molecular
weight of DOC2b and syntaxin-4 are 46 and 34 kDa,
respectively), it was difﬁcult to perform a reverse immu-
noprecipitation experiment. Third, our results were
conﬁrmed by immunoprecipitation experiments using adi-
pocytes expressing myc-tagged DOC2b (Fig. 3D and E). It
is important to note that we could not detect the interac-
tion between DOC2b and syntaxin-4 in the buffer contain-
ing EDTA (data not shown). Furthermore, we could not
ﬁnd interaction between DOC2b and syntaxin6 in 3T3-L1
adipocytes (online appendix Fig. S2).
To better assess the calcium dependency of DOC2b
translocation and interaction with syntaxin-4 in adipo-
cytes, we conducted the following additional experiments
using a Ca
2-unbound mutant. Based on the information
from crystallographic analysis of synaptotagmin-1 (16–
18), we created mutations in the putative Ca
2-binding
sites of DOC2b (i.e., C2A [D157N, D163N] and C2B
[D297N, D303N]) and designated the product obtained the
CIM (Fig. 4A). This type of mutant reportedly loses its cal-
cium-dependent phospholipids-targeting capacity (19,20).
As shown in Fig. 4B, the CIM mutation markedly inhibited
insulin-induced DOC2b translocation. Furthermore, CIM-
DOC2b also failed to interact with syntaxin-4 in both the in
vivo and the in vitro setting (Fig. 4C–E). These results
raise the possibility that Ca
2 binding is essential for
insulin-stimulated DOC2b translocation as well as the
interaction with syntaxin-4.
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FIG. 3. Insulin promotes Ca
2-dependent interaction between DOC2b and syntaxin-4. A: pLexA containing DOC2b or munc18c and pB42AD
containing munc18c, syntaxin-4 (synt.4) or empty vectors were coexpressed in the yeast strain of EGY48 (p8op-lacZ), followed by incubation at
30°C for 16 h. Transcriptional activation of LacZ was determined by -galactosidase assay. B: GST-tagged DOC2b and syntaxin-4 were bacterially
expressed. Syntaxin-4 protein was cleaved by PreScession protease and further puriﬁed with Amicon Ultra ﬁlter devices. Both proteins (1 g
each) were mixed in Tris-buffered saline in the presence of 2 mmol/l EDTA or 1 mmol/l CaCl2 and pulled down by glutathione sepharose. The
precipitates were analyzed by Western blotting with anti–syntaxin-4 and anti-GST antibodies. C: 3T3-L1 adipocytes were serum-starved for 3–4
h and pretreated with or without 50 mol/l of BAPTA-AM before insulin treatment. The DOC2b–syntaxin-4 interaction was determined by
immunoprecipitation using anti-DOC2b antibody. The immunoprecipitated proteins were immunoblotted with anti–syntaxin-4 and anti-DOC2b
antibodies. D and E: Myc-tagged DOC2b was expressed by adenovirus vector in 3T3-L1 adipocytes. After serum starvation and pretreatment with
or without 50 mol/l of BAPTA-AM, before insulin treatment, the cells were stimulated with or without 100 nmol/l of insulin for 20 min and then
immunoprecipitated with anti-myc or anti–syntaxin-4 antibodies. The immunoprecipitated proteins were immunoblotted with anti-myc and
anti–syntaxin-4 antibodies.
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response to insulin. One interpretation of the above
ﬁndings is that DOC2b may act as a Ca
2 sensor protein
for SNARE complexes triggering GLUT4 vesicle fusion. To
assess the role of DOC2b in GLUT4 vesicle fusion to the
plasma membrane, we utilized a GLUT4 construct contain-
ing four myc epitopes in the ﬁrst exofacial loop of GLUT4
and an eGFP fusion at its cytoplasmic COOH terminus.
These exofacial tags are easily detected by anti-myc
antibody but only when GLUT4 vesicles are fused to the
plasma membrane (21). Adipocytes expressing this GLUT4
construct and DsRed2-DOC2b (wild type or CIM) or
shRNAs were observed by confocal microscopy. As shown
in Fig. 5A and B, the externalized GLUT4 was increased in
the cells coexpressing wild-type DOC2b, while being de-
creased in those coexpressing CIM-DOC2b or shRNA
(shRNADOC2b) compared with the control cells. Since the
above conclusions were based on qualitative visual im-
pression, we next estimated the ﬂuorescent signals of the
cellular rims in Fig. 5A and B in two ways. First, we
counted the number of the cells with eGFP rims (50 cells
in each condition) in the cells expressing myc-GLUT4-
eGFP. As shown in Fig. 5C, just translocated or docked
GLUT4 detected by eGFP ﬂuorescence did not change
under either condition. Second, we quantiﬁed the ratio of
cell surface GLUT4 (myc sinal) to GLUT4 translocated to
plasma membrane (eGFP signal) as previously described
(22). As shown in Fig. 5D and E, cell surface GLUT4 was
increased in the cells expressing wild-type DOC2b but
decreased in those expressing CIM-DOC2b and silenced
DOC2b (Fig. 5D and E). These results, taken together with
the data shown in Fig. 5A, are consistent with the idea that
DOC2b is a calcium-sensing protein and regulates the
GLUT4 vesicle fusion step in response to insulin.
Role of DOC2b in glucose transport in 3T3-L1
adipocytes. We next focused on the role of DOC2b in
insulin-dependent glucose uptake in adipocytes express-
ing wild-type DOC2b and CIM-DOC2b. As shown in Fig.
6A, overexpression of wild-type DOC2b increased insulin-
stimulated glucose uptake to 122% of the control level. In
contrast, overexpression of CIM-DOC2b decreased to 78%
of the control level. Furthermore, we introduced shRNAs
(shRNADOC2b, control) by adenovirus vectors into cultured
adipocytes to induce speciﬁc degradation of the DOC2b
mRNA. DOC2b protein expression was decreased to 50
and 10% of the control level in the cells infected with
viruses at multiplicity of infection (MOI) of 20 and 50,
respectively (Fig. 6B). As expected, glucose uptake was
decreased from 87 to 60% in adipocytes infected with the
adenovirus vectors at MOI of 20–50 (Fig. 6B). To conﬁrm
the speciﬁcity of silencing, we conducted add-back style
rescue experiment using adenovirus vector containing
wild-type DOC2b. As shown in online appendix Fig. S3,
overexpression of DOC2b rescued the inhibitory effect on
glucose uptake in DOC2b-silenced cells. Under these con-
ditions, DOC2b overexpression and silencing had no ef-
fects on serine phosphorylation of Akt (Fig. 6A and B and
online appendix Fig. S3). These results, taken together
with the data presented in Figs. 2–5, suggest that DOC2b
regulates glucose transport through modulating vesicle
fusion processes but not insulin signaling.
DISCUSSION
Regulation of glucose uptake in muscle and adipose tissues
by insulin is of fundamental importance for proper mainte-
nance of postprandial hyperglycemia. This hormone stimu-
lates translocation of the GLUT4 glucose transporter from
the intracellular membrane to the cell surface (1,2). In
addition to this movement of intracellular vesicles containing
GLUT4, it has been suggested that the docking and fusion
step of GLUT4 vesicles is also critically regulated by insulin
(3,4,23). However, the precise mechanism by which insulin
regulates vesicle fusion is still largely unknown.
A key ﬁnding of this study is identiﬁcation of the double
C2 domain protein DOC2b, which mediates insulin-regu-
lated GLUT4 vesicle fusion. Like other membrane fusion
processes, GLUT4 vesicle fusion occurs essentially
through the formation of a “core complex” consisting of
syntaxin-4 and VAMP-2 (5). In general, however, a number
of additional factors are required to bring about SNARE-
mediated membrane fusion in vivo. Many of these factors,
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FIG. 4. Calcium binding to DOC2b is essential for its translocation and
interaction with syntaxin-4. A: ClustalW sequence alignment of
C2A and C2B domains from synaptotagmin-1, -2, -3, -5, and -9 and
DOC2a and DOC2b. Two aspartic acid residues in each C2 domain
(shown on a black background) are well-conserved putative Ca
2-
binding sites. These four aspartic acid residues were mutated into
asparagine for CIM-DOC2b (D157N, D163N, D297N, and D303N) con-
struction. B: Wild-type (WT) or calcium-interacting domain mutants
(CIM) of eGFP-DOC2b were expressed in 3T3-L1 adipocytes, which
were then treated with insulin and observed under a confocal micro-
scope. Figures show representative images of three independent ex-
periments. C: Puriﬁed GST-DOC2b (WT or CIM) and syntaxin-4 were
mixed in the presence of 2 mmol/l EDTA or 1 mmol/l of CaCl2 and pulled
down with glutathione sepharose. The precipitates were analyzed by
Western blotting with anti–syntaxin-4 and anti-GST antibodies. D and
E: Myc-tagged DOC2b (WT or CIM) was expressed in 3T3-L1 adipo-
cytes. After serum starvation, the cells were stimulated with or with-
out 100 nmol/l of insulin for 20 min and then immunoprecipitated with
anti-myc or anti–syntaxin-4 antibodies. The immunoprecipitated pro-
teins were immunoblotted with anti-myc and anti–syntaxin-4 antibodies.
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munc18, synaptotagmin, munc13, GATE-16/Apg8, LMA1, syn-
aptophysin, tomosyn, and Vsm1/Ddi1), bind directly to
SNARE proteins and are involved in membrane trafﬁcking
and fusion events (24). Among these SNARE regulators,
munc18c and tomosyn were reported to be negative regula-
tors of the SNARE complex assembly involved in GLUT4
vesicle fusion (25–27). Despite numerous investigations, the
positive SNARE regulators for GLUT4 vesicle fusion have not
been adequately clariﬁed. In this report, we have shown that
FIG. 5. DOC2b enhances GLUT4 vesicle fusion in 3T3-L1 adipocytes. A and B: Exofacial myc-tagged GLUT4-eGFP and DsRed2-DOC2b or
pcPUR-U6i-shRNADOC2b,control were coelectroporated into 3T3-L1 adipocytes. The cells were serum starved for 2–4 h and either untreated or
treated with 100 nmol/l of insulin for 20 min. The cells were then ﬁxed and stained with anti-myc antibody and Cy5-labeled secondary antibody
without detergents. In the cells electroporated with shRNAs, endogenous DOC2b were visualized with anti-DOC2b antibody, followed by
Cy3-labeled secondary antibody. Stained cells were observed by confocal microscopy. This shRNA system decreased DOC2b protein expression
to 10–20% of control level. Images are representative of three independent experiments. C–E: Percents of cells with GLUT4-eGFP rims and the
cell surface myc-GLUT4 contents (the ratio of myc signal/eGFP signal at plasma membrane rims) in Fig. 5A was calculated as described under
RESEARCH DESIGN AND METHODS. C: , insulin; f, insulin. D: , control; o, wild type; f, CIM. E: , shRNA control; f, shRNA DOC2b. The graphs
represent values from at least 3–5 independent experiments, and error bars show SD. (Please see http://dx.doi.org/10.2337/db08-0303 for a
high-quality digital representation of this ﬁgure.)
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sion in adipocytes, while having no effect on the GLUT4
vesicle translocation step. These data are consistent with the
hypothesis that DOC2b regulates insulin-stimulated GLUT4
vesicle fusion. DOC2b may be a positive SNARE regulator for
vesicle fusion processes in adipocytes.
A second signiﬁcant ﬁnding reported herein is the identi-
ﬁcation of a DOC2b binding partner. DOC2b interacts with
t-SNARE syntaxin-4 upon stimulation with insulin in the
presence of calcium. Syntaxin-4 is thought to be a SNARE
protein on the target membrane for GLUT4 vesicle fusion
(28,29). As shown in Fig. 3A, this interaction appears to be
very strong compared with that between munc18c and
syntaxin-4 demonstrated by the yeast two-hybrid method.
Although this interaction appeared to be very strong, SNARE
proteins are quite sticky and can on occasion bind with many
proteins nonspeciﬁcally. Therefore, we performed three ad-
ditional experiments. As shown in Fig. 3B–E, we conﬁrmed
the interaction between DOC2b and syntaxin-4 in both the in
vivo and the in vitro setting. Furthermore, changes in the
intracellular localization of DOC2b also supported the func-
tional interaction. As shown in Fig. 2A, DOC2b translocates
to the plasma membrane in response to insulin stimulation.
Importantly, the time scale of DOC2b translocation coincides
with relatively slow externalization of GLUT4 vesicles. Taken
together, our data are consistent with the aforementioned
hypothesis that DOC2b regulates GLUT4 vesicle fusion by
triggering SNARE complex assembly.
Another interesting observation made in this study is the
essential role of [Ca
2]i in insulin-stimulated GLUT4 vesicle
fusion. In 2001, Whitehead et al. (8) ﬁrst reported that a
calcium chelator, BAPTA-AM, inhibited GLUT4 externaliza-
tion and glucose uptake. However, the precise mechanism
underlying calcium-dependent GLUT4 vesicle fusion remains
unknown because no studies have as yet focused on Ca
2-
sensing proteins in adipocytes. DOC2b is structurally similar
to the well-known calcium-sensing SNARE regulator synap-
totagmins (Fig. 4A). Taking these observations together, we
hypothesized that DOC2b is a Ca
2-sensing protein that
regulates GLUT4 vesicle fusion in adipocytes. To better
assess the role of Ca
2 in GLUT4 vesicle fusion, we con-
ﬁrmed the following. First, DOC2b translocation and its
binding to syntaxin-4 were shown to be [Ca
2]i dependent.
Second, mutations in calcium-binding sites on C2 domains of
DOC2b resulted in loss of syntaxin-4 binding, GLUT4 exter-
nalization, and glucose uptake. In contrast, we also observed
DOC2b–syntaxin-4 binding, without insulin action, in a GST
pull-down assay, suggesting that [Ca
2]i is necessary for this
interaction in vitro (Fig. 3B). In parallel, we also found that
insulin initiates the DOC2b translocation to plasma mem-
brane and promotes interaction between DOC2b and syn-
taxin-4 in the presence of Ca
2 ions. Based on the above
observations, we propose a simple model whereby insulin
regulates SNARE regulator DOC2b, and basal level of [Ca
2]i
may act in a constitutive manner to promote DOC2b–syn-
taxin-4 interaction involved in insulin-stimulated GLUT4 ves-
icle fusion.
A recent report (30) suggests that DOC2 proteins remove
munc18 from syntaxin, thereby regulating core SNARE com-
plex formation. This interpretation is very attractive because
munc18c is thought to be a negative regulator of GLUT4
vesicle fusion. Although we have no direct data pertaining to
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FIG. 6. DOC2b regulates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. 3T3-L1 adipocytes were infected with recombinant adenovirus
vectors encoding eGFP, myc-tagged DOC2b (WT, CIM) at MOI of 50 (A and B) or adenovirus vectors encoding shRNA speciﬁc for DOC2b or
nontargeting control at MOI of 0, 20, and 50 (C and D). After serum starvation, the cells were treated with or without 100 nmol/l of insulin for
10 min. A: , control; o wild type;; f, CIM. C: ,0 ;o, 20; f, 50. 2-Deoxy-glucose uptake was measured under each condition. Results are presented
as means  SD of at least ﬁve independent experiments. B and D: The cell lysates were also immunoblotted with anti-myc, anti-GFP, anti-DOC2b,
anti-Akt, anti–phosphoserine-Akt, and anti–glyceraldehyde-3-phosphate dehydrogenase antibodies. Immunoblots were representative of at least
three independent experiments.
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modulate SNARE assembly in a counterregulatory manner.
Very recently, Ke et al. (31) reported that DOC2b bound
munc18c, but not syntaxin-4, in pancreatic -cells. This
apparent discrepancy on syntaxin-4 binding may be attribut-
able to the different experimental conditions. They per-
formed most of their experiments using a buffer without
calcium (i.e., Nonidet P-40 lysis buffer). Since DOC2b has
conserved Ca
2-binding sites and is thought to be a Ca
2
sensor protein in other cell types such as neuron (32) and
chromafﬁn cells (33), Ca
2 might be important for the
physiological properties of DOC2b in -cells. Further work is
required to uncover the underling mechanisms by which
DOC2b regulates SNARE assembly in response to insulin.
In summary, we have identiﬁed DOC2b as a syntaxin-4
binding protein in adipocytes. This protein regulates
GLUT4 vesicle fusion as well as glucose uptake in re-
sponse to insulin stimulation. We have further revealed
that DOC2b requires [Ca
2]i and positively regulates the
step of GLUT4 vesicle fusion.
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